Table 2.

Percentage of Donor-Type Gpi-1 Isoenzyme Present in the Peripheral Blood Cells of Primary Recipients Receiving Transplants at Birth of Day-10 PC Yolk Sac Cells Via Intraliver or Intravenous Routes

Cell TypeMonths Posttransplant
4611
B lymphocyte 
IL 36 ± 5 35 ± 7 36 ± 6 
IV 15 ± 1 12 ± 4 ND 
T lymphocyte 
IL 26 ± 7 28 ± 4 32 ± 6 
IV ND 10 ± 6 ND 
Granulocyte 
IL 33 ± 9 34 ± 10 31 ± 10 
IV 16 ± 9 19 ± 7 ND 
Red blood cell 
IL 35 ± 6 39 ± 8 37 ± 9 
IV 23 ± 5 25 ± 10 ND 
Cell TypeMonths Posttransplant
4611
B lymphocyte 
IL 36 ± 5 35 ± 7 36 ± 6 
IV 15 ± 1 12 ± 4 ND 
T lymphocyte 
IL 26 ± 7 28 ± 4 32 ± 6 
IV ND 10 ± 6 ND 
Granulocyte 
IL 33 ± 9 34 ± 10 31 ± 10 
IV 16 ± 9 19 ± 7 ND 
Red blood cell 
IL 35 ± 6 39 ± 8 37 ± 9 
IV 23 ± 5 25 ± 10 ND 

Data are presented as the mean ± SD of 3 representative animals (n = 16 for IL injections and n = 5 for IV injections).

Abbreviations: IL, intraliver; IV, intravenous; ND, not done.

or Create an Account

Close Modal
Close Modal